High Outlier
Strength
75 mg/1
Manufacturer
Sanofi-Aventis U.S. LLCNDC
00024117190
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
1/1/2026
Active Ingredients
CLOPIDOGREL BISULFATEApproval Type
New Drug (NDA)
FDA Application
NDA020839On Market Since
11/17/1997
Pharmacological Classes
Cytochrome P450 2C8 Inhibitors
Decreased Platelet Aggregation
P2Y12 Platelet Inhibitor
P2Y12 Receptor Antagonists
Related Drugs
Same classification
EXCEDRIN EXTRA STRENGTH GELTAB
Brand
00067202124•Haleon US Holdings LLC
$0.1205
per EA
EXCEDRIN EXTRA STRENGTH CAPLET
Brand
00067200020•Haleon US Holdings LLC
$0.1338
per EA
EXCEDRIN EXTRA STRENGTH CAPLET
Brand
00067200024•Haleon US Holdings LLC
$0.1338
per EA
EXCEDRIN EXTRA STRENGTH CAPLET
Brand
00067200033•Haleon US Holdings LLC
$0.1338
per EA
EXCEDRIN EXTRA STRENGTH CAPLET
Brand
00067200050•Haleon US Holdings LLC
$0.1338
per EA
EXCEDRIN EXTRA STRENGTH CAPLET
Brand
00067200077•Haleon US Holdings LLC
$0.1338
per EA
EXCEDRIN EXTRA STRENGTH CAPLET
Brand
00067200091•Haleon US Holdings LLC
$0.1338
per EA
EXCEDRIN MIGRAINE GELTAB
Brand
00067203520•Haleon US Holdings LLC
$0.1338
per EA
EXCEDRIN MIGRAINE CAPLET
Brand
00067203924•Haleon US Holdings LLC
$0.1338
per EA
EXCEDRIN MIGRAINE CAPLET
Brand
00067203933•Haleon US Holdings LLC
$0.1338
per EA